Liquid-crystalline medium and liquid-crystal display comprising the same

US11359142B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11359142-B2
Application numberUS-202017126087-A
CountryUS
Kind codeB2
Filing dateDec 18, 2020
Priority dateDec 20, 2019
Publication dateJun 14, 2022
Grant dateJun 14, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A liquid-crystalline medium, preferably having a nematic phase and dielectric anisotropy of 0.5 or more, which comprises one or more compounds of each of formulae T and L in which the parameters have the meanings given in the claims and in the text. The use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type. Also, the compounds of formulae T and L and their use for the improvement of the transmission and/or response times of a liquid-crystalline medium which comprises one or more additional mesogenic compounds.

First claim

Opening claim text (preview).

The invention claimed is: 1. A liquid-crystalline medium which comprises: one or more compounds of formula T in which R S1 denotes optionally fluorinated alkyl or optionally fluorinated alkoxy having 1 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene or 1,3-cyclo-pentenylene, or alkenyloxy, alkoxyalkyl or optionally fluorinated alkenyl having 2 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, R S2 denotes optionally fluorinated alkyl or optionally fluorinated alkoxy having 1 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene or 1,3-cyclo-pentenylene, or optionally fluorinated alkenyloxy, alkoxyalkyl or optionally fluorinated alkenyl having 2 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, or denotes, F, Cl, CN, or NCS, and Y S1 and Y S2 independently of one another, denote H or F, and wherein one or more of the aromatic rings in formula T are optionally substituted by an alkyl group; and one or more compounds of formula L in which R L1 denotes optionally fluorinated alkyl or optionally fluorinated alkoxy having 1 to 7 C atoms, wherein one —CH 2 — group are optionally replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, or optionally fluorinated alkenyl, or alkenyloxy or alkoxyalkyl of 2 to 7 C atoms, wherein one —CH 2 — group may be replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene or 1,3-cyclo-pentenylene, R L2 denotes optionally fluorinated alkyl or optionally fluorinated alkoxy having 1 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, or optionally fluorinated alkenyl, optionally fluorinated alkenyloxy or alkoxyalkyl of 2 to 7 C atoms, wherein one —CH 2 — group may be replaced by cyclo-propylene, 1,3-cyclobutylene, 1,3-cyclopentylene or 1,3-cyclo-pentenylene, or denotes F, Cl, CN, or NCS, and Y L1 and Y L2 independently of one another, denote H or F, and wherein the aromatic ring in formula L is optionally further substituted by an alkyl group. 2. The medium according to claim 1 , which comprises one or more compounds of formula T, which are selected from compounds of formulae T-1 and T-2: wherein R S1 , R S2 , Y S1 and Y S2 have the respective meanings given under formula T above, with the exception that R S2 in formula T-1 may not denote X S , and in which R S denotes optionally fluorinated alkyl or optionally fluorinated alkoxy; having 1 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclopropylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, or alkenyloxy, alkoxyalkyl or optionally fluorinated alkenyl having 2 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclopropylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, and X S denotes F, Cl, CN, NCS, fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy or fluorinated alkenyloxy, the fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy and fluorinated alkenyloxy groups having 1 to 4 C atoms, and wherein the one or more of the aromatic rings in formula T-2 are optionally be substituted by an alkyl group. 3. The medium according to claim 2 , which comprises one or more compounds of formula T-1. 4. The medium according to claim 1 , which comprises one or more compounds of formula L, which are selected from compounds of formulae L-1 and L-2: wherein R 1L , R 2L , Y L1 and Y L2 have the respective meanings given under formula L in claim 1 , with the exception that R L2 in formula L-1 may not denote X L , and in which R L denotes optionally fluorinated alkyl or optionally fluorinated alkoxy; having 1 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclopropylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, or alkenyloxy, alkoxyalkyl or optionally fluorinated alkenyl having 2 to 7 C atoms, wherein one —CH 2 — group is optionally replaced by cyclopropylene, 1,3-cyclobutylene, 1,3-cyclopentylene, or 1,3-cyclo-pentenylene, and X L denotes F, Cl, CN, NCS, fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy or fluorinated alkenyloxy, the fluorinated alkyl, fluorinated alkenyl, fluorinated alkoxy and fluorinated alkenyloxy groups having 1 to 4 C atoms, and wherein the aromatic ring in formulae L-1 and L-2 is optionally substituted by an alkyl group. 5. The medium according to claim 4 , which comprises one or more compounds of formula L-2. 6. The medium according to claim 4 , which comprises one or more compounds of formula L-1. 7. The medium according to claim 1 , which further comprises one or more compounds selected from compounds of formulae II and III: in which R 2 denotes optionally fluorinated alkyl or optionally fluorinated alkoxy having 1 to 7 C atoms, or alkenyloxy, alkoxyalkyl or optionally fluorinated alkenyl having 2 to 7 C atoms, on each appearance, independently of one another, denote L 21 and L 22 denote H or F, X 2 denotes halogen, halogenated alkyl or alkoxy having 1 to 3 C atoms or halogenated alkenyl or alkenyloxy having 2 or 3 C atoms, m denotes 0, 1, 2 or 3, R 3 denotes optionally fluorinated alkyl or optionally fluorinated alkoxy having 1 to 7 C atoms, or alkenyloxy, alkoxyalkyl or optionally fluorinated alkenyl having 2 to 7 C atoms on each appearance, independently of one another, are L 31 and L 32 , independently of one another, denote H or F, X 3 denotes halogen, halogenated alkyl or alkoxy having 1 to 3 C atoms or halogenated alkenyl or alkenyloxy having 2 or 3 C atoms, F, Cl, —OCF 3 , —OCHF 2 , —O—CH 2 CF 3 , —O—CH═CF 2 , —O—CH═CH 2 or —CF 3 , Z 3 denotes —CH 2 CH 2 —, —CF 2 CF 2 —, —COO—, trans-CH═CH—, trans-CF═CF—, —CH 2 O— or a single bond, and n denotes 0, 1, 2 or 3 and wherein the one or more of the aromatic rings in formulae II and III are optionally be substituted by an alkyl group, with the condition that the compounds of formula L are excluded from formula III. 8. The medium according to claim 1 , which further comprises one or more compounds of formulae IV and V:

Assignees

Inventors

Classifications

  • containing a heterocyclic ring · CPC title

  • the linking chain being a -CF=CF- chain, e.g. 1,2-difluoroethen-1,2-diyl · CPC title

  • Cy-Cy · CPC title

  • having sulfur as hetero atom · CPC title

  • Unsaturated non-aromatic rings, e.g. cyclohexene rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11359142B2 cover?
A liquid-crystalline medium, preferably having a nematic phase and dielectric anisotropy of 0.5 or more, which comprises one or more compounds of each of formulae T and L in which the parameters have the meanings given in the claims and in the text. The use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, …
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/3491. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).